Aimfinity Investment Corp. I Files 8-K Report
Ticker: AIMTF · Form: 8-K · Filed: Feb 10, 2025 · CIK: 1903464
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
AIMAU filed an 8-K on 2025-02-10, mostly standard disclosures.
AI Summary
On February 10, 2025, Aimfinity Investment Corp. I filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and includes Financial Statements and Exhibits. No specific financial transactions or material events were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates Aimfinity Investment Corp. I is providing updates or disclosures required by the SEC, which could be relevant for investors monitoring the company's regulatory compliance.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report with no immediate indication of significant financial changes or risks.
Key Players & Entities
- Aimfinity Investment Corp. I (company) — Registrant
- 0001213900-25-011508 (filing_id) — Accession Number
- February 10, 2025 (date) — Report Date
FAQ
What is the primary purpose of this 8-K filing for Aimfinity Investment Corp. I?
The filing is for Regulation FD Disclosure and includes Financial Statements and Exhibits, as reported on February 10, 2025.
What is the ticker symbol for Aimfinity Investment Corp. I?
The ticker symbol is not explicitly stated in the provided text, but the company name is Aimfinity Investment Corp. I.
When was this 8-K report filed?
The report was filed on February 10, 2025.
What are the main items disclosed in this 8-K filing?
The filing concerns Regulation FD Disclosure and Financial Statements and Exhibits.
What is the company's address as listed in the filing?
The company's business and mailing address is 1 ROCKEFELLER PLAZA, 11TH FLOOR, NY, NY 10020.
Filing Stats: 1,704 words · 7 min read · ~6 pages · Grade level 16.3 · Accepted 2025-02-10 08:02:24
Key Financial Figures
- $0.0001 — nsisting of one Class A ordinary share, $0.0001 par value, one Class 1 redeemable warra
- $11.50 — ordinary share at an exercise price of $11.50 AIMAW The Nasdaq Stock Market LLC
Filing Documents
- ea0230451-8k425_aimfinity1.htm (8-K) — 45KB
- ea023045101ex99-1_aimfinity1.htm (EX-99.1) — 38KB
- ea023045101ex99-2_aimfinity1.htm (EX-99.2) — 21KB
- 0001213900-25-011508.txt ( ) — 356KB
- aimau-20250210.xsd (EX-101.SCH) — 4KB
- aimau-20250210_def.xml (EX-101.DEF) — 27KB
- aimau-20250210_lab.xml (EX-101.LAB) — 38KB
- aimau-20250210_pre.xml (EX-101.PRE) — 26KB
- ea0230451-8k425_aimfinity1_htm.xml (XML) — 9KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On February 10, 2025, Aimfinity Investment Corp. I ("AIMA") issued a pair of press releases in Chinese and English providing certain updates regarding its business combination with Docter Inc., a Delaware corporation, as disclosed previously on the Current Report on Form 8-K filed on October 16, 2023. A copy of each press release is furnished as Exhibits 99.1 and 99.2 hereto. The information in this Item 7.01 and the press releases hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing. IMPORTANT NOTICES Important Notice Regarding Forward-Looking As disclosed previously on the Current Report on Form 8-K filed on October 16, 2023, on October 13, 2023, AIMA entered into that certain Merger Agreement, with Docter, Purchaser, and Merger Sub, pursuant to which AIMA will enter into a business combination with Docter that involves a reincorporation merger and an acquisition merger. This Current Report on Form 8-K contains certain "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended. Statements that are not historical facts, including statements about the pending transactions described above, and the parties' perspectives and expectations, are forward-looking statements. Such statements include, but are not limited to, statements regarding the proposed transaction, including the anticipated initial enterprise value and post-closing equity value, the benefits of the proposed transaction, integration plans, expected synergies and revenue opportunities, anticipated future financial and operating performance and results, including est
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release, dated February 10, 2025 (in Chinese) 99.2 Press Release, dated February 10, 2025 (in English) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aimfinity Investment Corp. I Date: February 10, 2025 By: /s/ I-Fa Chang Name: I-Fa Chang Title: Chief Executive Officer 3